{"DataElement":{"publicId":"2646564","version":"1","preferredName":"Kaposi Sarcoma Related Visceral Disease Assessment Status","preferredDefinition":"the status of a Kaposi Sarcoma related visceral disease evaluation.","longName":"KS_R_V_DZ_ASESS_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2640634","version":"1","preferredName":"Kaposi Sarcoma Related Visceral Disease Assessment","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related visceral disease (relating to or affecting the internal organs).","longName":"KS_R/T_VISC_DZ_ASESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2640632","version":"1","preferredName":"Kaposi Sarcoma Related Visceral Diseases and Disorders","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:Related; connected or associated.:Visceral; of, or relating to, or affecting the internal organs.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C9087:C25648:C25315:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Visceral","conceptCode":"C25315","definition":"Of, or relating to, or affecting the internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31138ADE-A5AE-3C80-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-22","modifiedBy":"ONEDATA","dateModified":"2007-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233077","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F90B5E56-BAFE-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-08","modifiedBy":"ONEDATA","dateModified":"2005-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3113924F-6189-3DAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646565","version":"1","preferredName":"Kaposi Sarcoma Related Visceral Disease Assessment Status","preferredDefinition":"the status of a Kaposi Sarcoma related visceral disease evaluation.","longName":"KS_R_V_DZ_ASESS_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"90","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"A complete resolution of visceral disease since baseline","valueDescription":"A complete resolution of visceral disease since baseline","ValueMeaning":{"publicId":"2646572","version":"1","preferredName":"A complete resolution of visceral disease since baseline","longName":"2646572","preferredDefinition":"A complete resolution of visceral disease since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321667F0-F2F3-31A6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321668AC-2421-2E7F-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"A decrease in visceral disease since baseline","valueDescription":"A decrease in visceral disease since baseline","ValueMeaning":{"publicId":"2646571","version":"1","preferredName":"A decrease in visceral disease since baseline","longName":"2646571","preferredDefinition":"A decrease in visceral disease since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32165758-0F37-2E61-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321668AC-2433-2E7F-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"A worsening of visceral disease since baseline, or since the best response","valueDescription":"A worsening of visceral disease since baseline, or since the best response","ValueMeaning":{"publicId":"2646570","version":"1","preferredName":"A worsening of visceral disease since baseline, or since the best response","longName":"2646570","preferredDefinition":"A worsening of visceral disease since baseline, or since the best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32166508-3F11-305D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321668AC-2445-2E7F-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Evidence of a new site of visceral disease since baseline, or since the best response","valueDescription":"Evidence of a new site of visceral disease since baseline, or since the best response","ValueMeaning":{"publicId":"2646569","version":"1","preferredName":"Evidence of a new site of visceral disease since baseline, or since the best response","longName":"2646569","preferredDefinition":"Evidence of a new site of visceral disease since baseline, or since the best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3216453A-3DA5-2E37-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321668AC-2457-2E7F-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"No change","valueDescription":"No Change","ValueMeaning":{"publicId":"2570474","version":"1","preferredName":"No Change","longName":"2570474","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: The act of alteration or modification; changed or altered in form or character.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321668AC-2463-2E7F-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32166CDA-5F3C-31BA-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Evidence of a new site of visceral disease","valueDescription":"Evidence of a new site of visceral disease","ValueMeaning":{"publicId":"5838512","version":"1","preferredName":"Evidence of a new site of visceral disease","longName":"5838512","preferredDefinition":"Evidence of a new site of visceral disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506EC036-BF8D-5348-E053-F662850A1239","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5070A03D-A1A8-44A0-E053-F662850A0076","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"Worsening of visceral disease since baseline","valueDescription":"Worsening of visceral disease since baseline","ValueMeaning":{"publicId":"5838514","version":"1","preferredName":"Worsening of visceral disease since baseline","longName":"5838514","preferredDefinition":"Worsening of visceral disease since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50704037-0F25-3211-E053-F662850AC758","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5070A03D-A1BC-44A0-E053-F662850A0076","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None of the above","ValueMeaning":{"publicId":"2577583","version":"1","preferredName":"None of the above","longName":"2577583v1.00","preferredDefinition":"None of the choices above are suitable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None of the Above","conceptCode":"C133298","definition":"None of the choices above are suitable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC1C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81CE7F-A9A6-2631-E053-4EBD850A9D32","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","valueDescription":">25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","ValueMeaning":{"publicId":"7372098","version":"1","preferredName":">25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","longName":"7372098","preferredDefinition":">25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81CE7F-A9B0-2631-E053-4EBD850A9D32","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81CE7F-A9C9-2631-E053-4EBD850A9D32","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=50% decrease of measurable lesions without unequivocal worsening of non-measurable disease","valueDescription":">=50% decrease of measurable lesions without unequivocal worsening of non-measurable disease","ValueMeaning":{"publicId":"7372099","version":"1","preferredName":">=50% decrease of measurable lesions without unequivocal worsening of non-measurable disease","longName":"7372099","preferredDefinition":">=50% decrease of measurable lesions without unequivocal worsening of non-measurable disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81CE7F-A9D3-2631-E053-4EBD850A9D32","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81CE7F-A9EC-2631-E053-4EBD850A9D32","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"A complete resolution of visceral disease","valueDescription":"A complete resolution of visceral disease","ValueMeaning":{"publicId":"7372100","version":"1","preferredName":"A complete resolution of visceral disease","longName":"7372100","preferredDefinition":"A complete resolution of visceral disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81CE7F-A9F6-2631-E053-4EBD850A9D32","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81CE7F-AA0F-2631-E053-4EBD850A9D32","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","valueDescription":">=25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","ValueMeaning":{"publicId":"7484964","version":"1","preferredName":">=25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","longName":"7484964","preferredDefinition":">=25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2BFA602-2649-6B37-E053-4EBD850A8111","latestVersionIndicator":"Yes","beginDate":"2020-10-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-28","modifiedBy":"ONEDATA","dateModified":"2020-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2BFA602-2662-6B37-E053-4EBD850A8111","beginDate":"2020-10-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-28","modifiedBy":"ONEDATA","dateModified":"2020-10-28","deletedIndicator":"No"},{"value":"<25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","valueDescription":"<25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","ValueMeaning":{"publicId":"7484965","version":"1","preferredName":"<25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","longName":"7484965","preferredDefinition":"<25% increase of measurable lesions and/or unequivocal worsening of non-measurable disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2BFA602-266C-6B37-E053-4EBD850A8111","latestVersionIndicator":"Yes","beginDate":"2020-10-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-28","modifiedBy":"ONEDATA","dateModified":"2020-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2BFA602-2685-6B37-E053-4EBD850A8111","beginDate":"2020-10-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-28","modifiedBy":"ONEDATA","dateModified":"2020-10-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32165758-0F21-2E61-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"CAMPBELB","dateModified":"2020-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"QSORRES_VISEVAL","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Visceral Evaluation","type":"Preferred Question Text","description":"Visceral Evaluation","url":null,"context":"CTEP"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Evaluation of visceral lesions","url":null,"context":"Theradex"},{"name":"AMC Question Text","type":"Alternate Question Text","description":"Visceral disease evaluation","url":null,"context":"AMC"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32164E3B-723A-2E41-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-04","modifiedBy":"COLLIED","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}